|
LMAN2L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.55040000002516E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.796160E-01 |
| Stage1-vs-Stage3 |
2.885600E-02 |
| Stage1-vs-Stage4 |
5.997700E-03 |
| Stage2-vs-Stage3 |
1.654320E-02 |
| Stage2-vs-Stage4 |
3.119900E-03 |
| Stage3-vs-Stage4 |
3.043600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.51533999999121E-05 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
6.917800E-01 |
| Caucasian-vs-Asian |
8.115600E-01 |
| AfricanAmerican-vs-Asian |
6.750000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64201985342061E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.098400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
3.96860322382508E-12 |
| Normal-vs-Age(81-100Yrs) |
1.37749999995496E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.911000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.137000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.159800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.770400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.646600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.824600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.22290000243086E-08 |
| Classical-VS-Follicular |
1.648310E-04 |
| Classical-VS-Other |
7.781000E-01 |
| Classical-VS-Normal |
1.6242562850266E-12 |
| Tall-VS-Follicular |
2.1696977547947E-11 |
| Tall-VS-Other |
9.378200E-02 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
3.179200E-01 |
| Follicular-VS-Normal |
1.89939999994948E-06 |
| Other-VS-Normal |
1.563530E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71218594857692E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
1.21940013642075E-10 |
|
|
